Huoxiang Zhengqi Oral Liquid Attenuates LPS-Induced Acute Lung Injury by Modulating Short-Chain Fatty Acid Levels and TLR4/NF-κB p65 Pathway

Huoxiang Zhengqi Oral Liquid (HZOL) is a classic Chinese patent medicine used in China for more than 1,000 years in treating gastrointestinal and respiratory diseases. Clinically applied HZOL in early respiratory disease stages can reduce the proportion of lung infection patients that progress to se...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Ruying, Zhang, Jianjun, Zhang, Rui, Li, Xinyu, Lv, Ruilin, Nan, Haipeng, Liu, Jinlian, Zhao, Zhongpeng, He, Wei, Wang, Linyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957650/
https://www.ncbi.nlm.nih.gov/pubmed/36845637
http://dx.doi.org/10.1155/2023/6183551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957650/
https://www.ncbi.nlm.nih.gov/pubmed/36845637
http://dx.doi.org/10.1155/2023/6183551

Ejemplares similares